Back to Search
JACOB R DUTCHER MD
MD
Interventional Cardiology Physician
NPI: 1619000999IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
102900(MN)43641(MN)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
43641(MN)
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 2000
Research & Publications (20)
In situ characterization of differences in the viscoelastic response of individual gram-negative and gram-positive bacterial cells.
PMID 19581369·J Bacteriol·2009
8-other
Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
PMID 19492080·PLoS Biol·2009
7-preclinical
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.
PMID 19190339·Cancer Res·2009
7-preclinical
Absolute quantitation of bacterial biofilm adhesion and viscoelasticity by microbead force spectroscopy.
PMID 19348775·Biophys J·2009
8-other
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
PMID 19229667·Med Oncol·2009
3-trial
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
PMID 19652060·J Clin Oncol·2009
3-trial
Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.
PMID 19526589·Cancer·2009
3-trial
Molecular resolution imaging of an antibiotic peptide in a lipid matrix.
PMID 19368392·J Am Chem Soc·2009
8-other
In situ PM-IRRAS studies of an archaea analogue thiolipid assembled on a au(111) electrode surface.
PMID 19499931·Langmuir·2009
8-other
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
PMID 18792064·Cancer·2008
3-trial
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206.
PMID 18936475·J Clin Oncol·2008
3-trial
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
PMID 18467720·J Clin Oncol·2008
3-trial
Use of atomic force microscopy and transmission electron microscopy for correlative studies of bacterial capsules.
PMID 18606791·Appl Environ Microbiol·2008
4-observational
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
PMID 18779536·Oncologist·2008
6-review
Surface viscoelasticity of individual gram-negative bacterial cells measured using atomic force microscopy.
PMID 18408030·J Bacteriol·2008
8-other
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.
PMID 17545537·Clin Cancer Res·2007
3-trial
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma.
PMID 17761980·J Clin Oncol·2007
3-trial
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.
PMID 17508219·J Cancer Res Clin Oncol·2007
3-trial
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
PMID 17538086·N Engl J Med·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 SIXTH AVE N
ST CLOUD, MN 56303 - Phone
- (320) 656-7020
Quick Facts
- NPI
- 1619000999
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile